ACCURAY INCORPORATED Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
ACCURAY INCORPORATED (ARAY) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$87.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-11-05
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-09-30 was -$87.00K, a 106.56% decline year-over-year.
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-09-30 was $1.33M.
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-09-30 was -$1.33M.
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-09-30 was -$2.17M.
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $1.66M.
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$1.35M, a 548.34% decline from fiscal 2023.
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $302.00K.
- ACCURAY INCORPORATED effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$5.56M, a 666.29% decline from fiscal 2021.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$87.00K 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | $1.66M 10-K · filed 2025-08-28 | |||
| 2025-03-31 | $812.00K 10-Q · filed 2025-05-02 | |||
| 2024-12-31 | -$414.00K 10-Q · filed 2025-02-05 | |||
| 2024-09-30 | $1.33M 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | -$1.35M 10-K · filed 2025-08-28 | |||
| 2024-03-31 | -$869.00K 10-Q · filed 2025-05-02 | |||
| 2023-12-31 | $1.07M 10-Q · filed 2025-02-05 | |||
| 2023-09-30 | -$1.33M 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $302.00K 10-K · filed 2024-09-19 | |||
| 2023-03-31 | $333.00K 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$79.00K 10-Q · filed 2024-02-07 | |||
| 2022-09-30 | -$2.17M 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | -$5.56M 10-K · filed 2024-09-19 | |||
| 2022-03-31 | -$2.33M 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | -$747.00K 10-Q · filed 2023-02-02 | |||
| 2021-09-30 | -$654.00K 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | $982.00K 10-K · filed 2023-09-07 | |||
| 2021-03-31 | $127.00K 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | $3.30M 10-Q · filed 2022-01-28 | |||
| 2020-09-30 | $1.49M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $234.00K 10-K · filed 2022-08-17 | |||
| 2020-03-31 | -$675.00K 10-Q · filed 2021-04-30 | |||
| 2019-12-31 | $28.00K 10-Q · filed 2021-02-01 | |||
| 2019-09-30 | -$1.85M 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | $124.00K 10-K · filed 2021-08-17 | |||
| 2019-03-31 | -$937.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$266.00K 10-Q · filed 2020-02-04 | |||
| 2018-09-30 | -$377.00K 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | -$346.00K 10-K · filed 2020-08-25 | |||
| 2018-03-31 | $2.53M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $891.00K 10-Q · filed 2019-02-08 | |||
| 2017-09-30 | $684.00K 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | $197.00K 10-K · filed 2019-08-23 | |||
| 2017-03-31 | -$2.35M 10-Q · filed 2018-05-02 | |||
| 2016-12-31 | -$3.65M 10-Q · filed 2018-02-05 | |||
| 2016-09-30 | $584.00K 10-Q · filed 2017-11-03 | |||
| 2016-06-30 | -$1.01M 10-K · filed 2018-08-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |